# Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis

> **NCT05322070** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Alimera Sciences** · enrollment: 125 (estimated)

## Conditions studied

- Uveitis, Posterior

## Interventions

- **DRUG:** Fluocinolone Acetonide Intravitreal Implant 0.18 mg

## Key facts

- **NCT ID:** NCT05322070
- **Lead sponsor:** Alimera Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-06-06
- **Primary completion:** 2025-11
- **Final completion:** 2025-11
- **Target enrollment:** 125 (ESTIMATED)
- **Last updated:** 2024-08-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05322070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05322070, "Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05322070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*